-
ABILIFY 1 mg/ml oral solution
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 10 mg orodispersible tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 10 mg tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 15 mg orodispersible tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 15 mg tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 30 mg orodispersible tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 30 mg tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 5 mg tablets
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
ABILIFY 7.5 mg/ml solution for injection
- admission: Great Britain
- Producer: Otsuka Pharmaceutical Europe Ltd.
- ATC-Code: N05AX12
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Aripiprazole
-
Ablavar 0.25 mmol/ml solution for injection
- admission: Great Britain
- Producer: TMC Pharma Services Ltd.
- ATC-Code: V08CA
- Active Substance: Gadofosveset Trisodium
-
Abseamed 1,000 IU/0.5 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 10,000 IU/1 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 2,000 IU/1 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 20,000 IU/0.5 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 3,000 IU/0.3 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 30,000 IU/0.75 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 4,000 IU/0.4 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 40,000 IU/1 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 5,000 IU/0.5 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 6,000 IU/0.6 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 7,000 IU/0.7 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 8,000 IU/0.8 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Abseamed 9,000 IU/0.9 ml solution for injection in a pre-filled syringe
- admission: Great Britain
- Producer: Medice Arzneimittel Pütter GmbH & Co. KG
- ATC-Code: B03XA01
- Therapeutic Area: Anemia
- Active Substance: Epoetin Alfa
-
Aclasta 5 mg solution for infusion
- admission: Great Britain
- Producer: Novartis Europharm Ltd.
- ATC-Code: M05BA08
- Therapeutic Area: Osteoporosis, Osteoporosis, Osteitis Deformans
- Active Substance: Zoledronic Acid
-
Actos 15 mg tablets
- admission: Great Britain
- Producer: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Active Substance: Pioglitazone, Hydrochloride
-
Actos 30 mg tablets
- admission: Great Britain
- Producer: Takeda Global Research and Development Centre (Europe) Ltd.
- ATC-Code: A10BG03
- Active Substance: Pioglitazone, Hydrochloride